• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • AstraZeneca transfers rights for Eklira and Duaklir to Covis Pharma EuropeanPharmaceuticalReview
    November 05, 2021
    AstraZeneca has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma.
  • Circassia pulls plug on AZ agreement pharmatimes
    April 10, 2020
    Circassia Pharmaceuticals is pulling back from its development and commercialisation agreement with AstraZeneca for US commercial rights to COPD therapies Tudorza (aclidinium) and Duaklir (aclidinium/formoterol).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service